Agreed, if all you are considering is efficacy.
But the high roll over into Lilac suggests that there were no issues with side effects or safety concerns by parents.
The FDA is more likely to approve a new drug, even with limited efficacy, if a) there are no other treatments and 2) there are no safety or tolerance issues.
Agreed, if all you are considering is efficacy.But the high roll...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.61 |
Change
0.400(2.63%) |
Mkt cap ! $1.996B | |||
| Open | High | Low | Value | Volume |
| $15.51 | $15.82 | $15.46 | $2.639M | 169.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 2099 | $15.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.62 | 404 | 19 |
View Market Depth
| Last trade - 13.01pm 30/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |